• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于比较临床试验中连续非正态结果的胜率方法。

A win ratio approach to comparing continuous non-normal outcomes in clinical trials.

作者信息

Wang Duolao, Pocock Stuart

机构信息

Biostatistics Unit, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.

Department of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

出版信息

Pharm Stat. 2016 May;15(3):238-45. doi: 10.1002/pst.1743. Epub 2016 Mar 11.

DOI:10.1002/pst.1743
PMID:26970432
Abstract

Clinical trials are often designed to compare continuous non-normal outcomes. The conventional statistical method for such a comparison is a non-parametric Mann-Whitney test, which provides a P-value for testing the hypothesis that the distributions of both treatment groups are identical, but does not provide a simple and straightforward estimate of treatment effect. For that, Hodges and Lehmann proposed estimating the shift parameter between two populations and its confidence interval (CI). However, such a shift parameter does not have a straightforward interpretation, and its CI contains zero in some cases when Mann-Whitney test produces a significant result. To overcome the aforementioned problems, we introduce the use of the win ratio for analysing such data. Patients in the new and control treatment are formed into all possible pairs. For each pair, the new treatment patient is labelled a 'winner' or a 'loser' if it is known who had the more favourable outcome. The win ratio is the total number of winners divided by the total numbers of losers. A 95% CI for the win ratio can be obtained using the bootstrap method. Statistical properties of the win ratio statistic are investigated using two real trial data sets and six simulation studies. Results show that the win ratio method has about the same power as the Mann-Whitney method. We recommend the use of the win ratio method for estimating the treatment effect (and CI) and the Mann-Whitney method for calculating the P-value for comparing continuous non-Normal outcomes when the amount of tied pairs is small. Copyright © 2016 John Wiley & Sons, Ltd.

摘要

临床试验通常旨在比较连续的非正态结果。用于此类比较的传统统计方法是非参数曼-惠特尼检验,它提供一个P值来检验两个治疗组分布相同的假设,但没有提供一个简单直接的治疗效果估计值。为此,霍奇斯和莱曼提出估计两个总体之间的偏移参数及其置信区间(CI)。然而,这样的偏移参数没有直接的解释,并且当曼-惠特尼检验产生显著结果时,其置信区间在某些情况下会包含零。为了克服上述问题,我们引入使用胜率来分析此类数据。新治疗组和对照组的患者组成所有可能的配对。对于每一对,如果知道谁的结果更有利,新治疗组的患者就被标记为“胜者”或“败者”。胜率是胜者总数除以败者总数。可以使用自助法获得胜率的95%置信区间。使用两个真实试验数据集和六个模拟研究来研究胜率统计量的统计特性。结果表明,胜率法的检验效能与曼-惠特尼法大致相同。我们建议,当平局配对数量较少时,使用胜率法来估计治疗效果(和置信区间),使用曼-惠特尼法来计算比较连续非正态结果的P值。版权所有© 2016约翰·威利父子有限公司。

相似文献

1
A win ratio approach to comparing continuous non-normal outcomes in clinical trials.一种用于比较临床试验中连续非正态结果的胜率方法。
Pharm Stat. 2016 May;15(3):238-45. doi: 10.1002/pst.1743. Epub 2016 Mar 11.
2
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.胜率:一种基于临床重点的临床试验中综合终点分析的新方法。
Eur Heart J. 2012 Jan;33(2):176-82. doi: 10.1093/eurheartj/ehr352. Epub 2011 Sep 6.
3
A win ratio approach for comparing crossing survival curves in clinical trials.一种用于比较临床试验中交叉生存曲线的赢率比方法。
J Biopharm Stat. 2023 Jul 4;33(4):488-501. doi: 10.1080/10543406.2023.2170393. Epub 2023 Feb 7.
4
A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components.一种用于分析复合终点的胜率的广义解析解,该解析解考虑了各组成部分之间的临床重要性顺序。
Pharm Stat. 2016 Sep;15(5):430-7. doi: 10.1002/pst.1763. Epub 2016 Aug 2.
5
Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.非正态分布数据的随机试验分析中的参数统计与非参数统计
BMC Med Res Methodol. 2005 Nov 3;5:35. doi: 10.1186/1471-2288-5-35.
6
Weighted win loss approach for analyzing prioritized outcomes.用于分析优先结果的加权胜负方法。
Stat Med. 2017 Jul 10;36(15):2452-2465. doi: 10.1002/sim.7284. Epub 2017 Mar 26.
7
Graphing the Win Ratio and its components over time.绘制胜率及其各组成部分随时间的变化图。
Stat Med. 2019 Jan 15;38(1):53-61. doi: 10.1002/sim.7895. Epub 2018 Sep 11.
8
Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method.使用合并重采样方法的非参数自助检验对小样本量研究进行分析。
Stat Med. 2017 Jun 30;36(14):2187-2205. doi: 10.1002/sim.7263. Epub 2017 Mar 9.
9
Wilcoxon-Mann-Whitney test: stratify or not?威尔科克森-曼-惠特尼检验:是否分层?
J Biopharm Stat. 2008;18(6):1103-11. doi: 10.1080/10543400802369103.
10
Adjusted win ratio with stratification: Calculation methods and interpretation.调整后的分层胜率:计算方法与解读。
Stat Methods Med Res. 2021 Feb;30(2):580-611. doi: 10.1177/0962280220942558. Epub 2020 Jul 29.

引用本文的文献

1
The Wilcoxon-Mann-Whitney Estimand Versus Differences in Medians or Means.威尔科克森-曼-惠特尼估计量与中位数或均值差异
Pharm Stat. 2025 Sep-Oct;24(5):e70036. doi: 10.1002/pst.70036.
2
Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should care.重症肌无力临床试验中的救援治疗处理:为何重要以及你为何应予以关注。
Ann Clin Transl Neurol. 2025 May;12(5):888-897. doi: 10.1002/acn3.52309. Epub 2025 Apr 16.
3
Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study.
维生素E(300毫克)治疗马兜铃酸肾病:一项多中心、随机、双盲、安慰剂对照研究。
Cell Rep Med. 2025 Feb 18;6(2):101939. doi: 10.1016/j.xcrm.2025.101939.
4
The Win Ratio Approach in Bayesian Monitoring for Two-Arm Phase II Clinical Trial Designs With Multiple Time-To-Event Endpoints.双臂II期临床试验设计中具有多个事件发生时间终点的贝叶斯监测中的胜率方法
Stat Med. 2024 Dec 30;43(30):5922-5934. doi: 10.1002/sim.10282. Epub 2024 Nov 25.
5
The win ratio in cardiology trials: lessons learnt, new developments, and wise future use.心脏病学试验中的胜率:经验教训、新进展和明智的未来应用。
Eur Heart J. 2024 Nov 21;45(44):4684-4699. doi: 10.1093/eurheartj/ehae647.
6
Win Statistics in Observational Cancer Research: Integrating Clinical and Quality-of-Life Outcomes.观察性癌症研究中的获胜统计:整合临床和生活质量结果
J Clin Med. 2024 May 31;13(11):3272. doi: 10.3390/jcm13113272.
7
Endovascular treatment versus standard medical treatment in patients with established large infarct: a cohort study.已发生大面积梗死患者的血管内治疗与标准药物治疗的比较:一项队列研究。
Int J Surg. 2024 Aug 1;110(8):4775-4784. doi: 10.1097/JS9.0000000000001539.
8
Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial.哌拉西林-他唑巴坦与美罗培南治疗头孢曲松不敏感的大肠埃希菌或肺炎克雷伯菌血流感染的疗效比较的优势比分析:来自 MERINO 试验的事后洞察。
Clin Infect Dis. 2024 Jun 14;78(6):1482-1489. doi: 10.1093/cid/ciae050.
9
The win ratio method in heart failure trials: lessons learnt from EMPULSE.心力衰竭试验中的赢率法:来自 EMPULSE 的经验教训。
Eur J Heart Fail. 2023 May;25(5):632-641. doi: 10.1002/ejhf.2853. Epub 2023 Apr 23.
10
Group sequential methods for the Mann-Whitney parameter.Mann-Whitney 参数的分组序贯方法。
Stat Methods Med Res. 2022 Oct;31(10):2004-2020. doi: 10.1177/09622802221107103. Epub 2022 Jun 13.